Atara Biotherapeutics (ATRA) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $404000.0.
- Atara Biotherapeutics' Accumulated Depreciation & Amortization fell 9776.14% to $404000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $404000.0, marking a year-over-year decrease of 9776.14%. This contributed to the annual value of $17.3 million for FY2024, which is 906.17% up from last year.
- Per Atara Biotherapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $404000.0 for Q3 2025, which was down 9776.14% from $375000.0 recorded in Q2 2025.
- In the past 5 years, Atara Biotherapeutics' Accumulated Depreciation & Amortization ranged from a high of $18.0 million in Q3 2024 and a low of $375000.0 during Q2 2025
- Its 4-year average for Accumulated Depreciation & Amortization is $11.8 million, with a median of $13.3 million in 2023.
- In the last 5 years, Atara Biotherapeutics' Accumulated Depreciation & Amortization surged by 2936.3% in 2023 and then plummeted by 9784.51% in 2025.
- Atara Biotherapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $12.4 million in 2022, then grew by 27.75% to $15.9 million in 2023, then grew by 9.06% to $17.3 million in 2024, then tumbled by 97.67% to $404000.0 in 2025.
- Its last three reported values are $404000.0 in Q3 2025, $375000.0 for Q2 2025, and $1.7 million during Q1 2025.